TrialPaediatric drugs2019

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial.

Edwin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.